Saturday, October 17, 2020 2:45:45 PM
I said, I 'hope' Dr Williams has some comments. Another 'popular' drug in similar Phase 2b Trials has had their leaders give semi-supported guidance from an uncompleted Phase 2b Trial and I didn't want that. I thought it might be common to give a general "we have confidence in the current Trial Data" kind of thing 'AFTER' last patient is enrolled/dosed. I agree REAL DATA is found on the CT.Gov site, all else is opinions from ('dudes') or unsubstantiated questionable hype/bash.
Thanks for also confirming that a Phase 2b Trial with success moves to a Real Life Phase 3 for statistical significance.
Maybe the 'Rights'(?) might be sold to a Biggie Pharma or maybe a partnership, using them to continue with further Trials and for marketing/production after a COMPLETED Phase 2b CT has significant enough Data.?.
AGN doesn't carry the 'big stick' to push things thru like a Big Pharma might do and can more easily afford.
Your opinions, evaluations and inputs were missed and appreciated...GLTA...
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM